Hansen M K, Nymoen U, Horsberg T E
Department of Pharmacology, Microbiology and Food Hygiene, Norwegian School of Veterinary Science, Oslo, Norway.
J Vet Pharmacol Ther. 2003 Apr;26(2):95-103. doi: 10.1046/j.1365-2885.2003.00454.x.
Metomidate was administered to halibut (Hippoglossus hippoglossus) and turbot (Scophthalmus maximus) intravenously at a dose of 3 mg/kg bodyweight, as a bath treatment at a dose of 9 mg/L water for 5 min to study the disposition of metomidate, and as bath treatment (9 mg/L) for 10 min to study the absorption and effect of metomidate on respiration and balance/motor control. Additionally, turbot were given metomidate orally at a dose of 7 mg/kg. The studies were performed in seawater at a temperature of 10.3 +/- 0.4 degrees C (halibut) and 18.0 +/- 0.3 degrees C (turbot). Pharmacokinetic modeling of the data showed that metomidate had shorter elimination half-life and higher plasma concentrations in turbot compared with halibut, both species displaying a rapid uptake, distribution and excretion. Following intravenous administration, the volumes of distribution at steady state (Vd(ss)) were 0.21 L/kg (halibut) and 0.44 L/kg (turbot). Plasma clearances (Cl) were 0.099 L/h.kg in halibut and 0.26 L/h.kg in turbot and the elimination half-lives (t(1/2)lambdaz) were calculated to be 5.8 h and 2.2 h in halibut and turbot, respectively. Mean residence times (MRT) were 2.2 h in halibut and 1.7 h in turbot. Following oral administration, the t(1/2)lambdaz was 3.5 h in turbot. The maximum plasma concentration (Cmax) was 7.8 mg/L in turbot 1 h after administration. The oral bioavailability (F) was calculated to 100% in turbot. Following 5 min bath the maximum plasma concentrations (Cmax), which were observed immediately after end of the bath, were 9.5 mg/L and 13.3 mg/L in halibut and turbot, respectively. Metomidate rapidly immobilized the fish, with respiratory depression, reduced heart rate, and loss of balance/motor control within 1 min (mean). Recovery was slow, with resumed balance/motor control after 26.4 min. Opercular respiration movements were resumed more rapidly with a recorded mean of 1.7 min. Oral administration was demonstrated to be a way of immobilizing fish, for example in large aquariums, without exposing them to unwanted stress.
给大比目鱼(庸鲽)和大菱鲆静脉注射咪达唑仑,剂量为3毫克/千克体重;将其作为药浴处理,剂量为9毫克/升水,持续5分钟,以研究咪达唑仑的处置情况;作为药浴处理(9毫克/升),持续10分钟,以研究咪达唑仑的吸收及其对呼吸和平衡/运动控制的影响。此外,给大菱鲆口服咪达唑仑,剂量为7毫克/千克。研究在海水中进行,水温为10.3±0.4摄氏度(大比目鱼)和18.0±0.3摄氏度(大菱鲆)。对数据进行药代动力学建模表明,与大比目鱼相比,大菱鲆的咪达唑仑消除半衰期更短,血浆浓度更高,两种鱼均表现出快速摄取、分布和排泄。静脉注射后,稳态分布容积(Vd(ss))在大比目鱼中为0.21升/千克,在大菱鲆中为0.44升/千克。血浆清除率(Cl)在大比目鱼中为0.099升/小时·千克,在大菱鲆中为0.26升/小时·千克,消除半衰期(t(1/2)λz)在大比目鱼和大菱鲆中分别计算为5.8小时和2.2小时。平均驻留时间(MRT)在大比目鱼中为2.2小时,在大菱鲆中为1.7小时。口服给药后,大菱鲆的t(1/2)λz为3.5小时。给药后1小时,大菱鲆的最大血浆浓度(Cmax)为7.8毫克/升。大菱鲆的口服生物利用度(F)计算为100%。药浴5分钟后,药浴结束后立即观察到的最大血浆浓度(Cmax)在大比目鱼和大菱鲆中分别为9.5毫克/升和13.3毫克/升。咪达唑仑能迅速使鱼失去活动能力,1分钟内(平均)出现呼吸抑制、心率降低以及平衡/运动控制丧失。恢复缓慢,26.4分钟后恢复平衡/运动控制。鳃呼吸运动恢复得更快,记录的平均时间为1.7分钟。口服给药被证明是一种使鱼失去活动能力的方法,例如在大型水族箱中,而不会使它们受到不必要的应激。